IMPAX LABORATORIES INC (IPXL) Stock Price, Quote, News and Overview
NASDAQ:IPXL - Nasdaq - US45256B1017
IPXL Quote, Performance and Key Statistics
18.3
0 (0%)
The current stock price of IPXL is 18.3 null. In the past month the price decreased by -3.43%. In the past year, price increased by 38.64%.
About IPXL
Company Profile
Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company engaged in the development, manufacture, and marketing of specialty prescription pharmaceutical products utilizing its own formulation expertise and drug delivery technologies. IMPAX Laboratories is focusing on two key areas, namely Generic Pharmaceutical Products and Branded Pharmaceutical Products. In the generic pharmaceuticals market, it focuses its efforts on controlled-release generic versions of selected brand-name pharmaceuticals covering a range of therapeutic areas. In the brand-name pharmaceuticals market, Impax is developing products for the treatment of central nervous system disorders. The company sells its products to large pharmaceutical wholesalers, warehousing chain drug stores, mass merchandisers, and mail-order pharmacies through strategic alliances and the company's global pharmaceuticals division.
Company Info
IMPAX LABORATORIES INC
30831 HUNTWOOD AVENUE
HAYWARD CA 94544
CEO: Paul M. Bisaro
Phone: 510-476-2000
IMPAX LABORATORIES INC / IPXL FAQ
What is the stock price of IMPAX LABORATORIES INC today?
The current stock price of IPXL is 18.3 null.
What is the ticker symbol for IMPAX LABORATORIES INC stock?
The exchange symbol of IMPAX LABORATORIES INC is IPXL and it is listed on the Nasdaq exchange.
On which exchange is IPXL stock listed?
IPXL stock is listed on the Nasdaq exchange.
What is IMPAX LABORATORIES INC worth?
IMPAX LABORATORIES INC (IPXL) has a market capitalization of 1.35B null. This makes IPXL a Small Cap stock.
What are the support and resistance levels for IMPAX LABORATORIES INC (IPXL) stock?
IMPAX LABORATORIES INC (IPXL) has a support level at 18.29 and a resistance level at 18.45. Check the full technical report for a detailed analysis of IPXL support and resistance levels.
Should I buy IMPAX LABORATORIES INC (IPXL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IPXL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IPXL, evaluating the profitability, health, valuation and growth aspects
- IMPAX LABORATORIES INC (IPXL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- IMPAX LABORATORIES INC (IPXL) Sales and EPS estimates to see what analysts future expectations are.
- IMPAX LABORATORIES INC (IPXL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- IMPAX LABORATORIES INC (IPXL) Insider and Institutional Ownership to learn about the owners and their transactions.
- IMPAX LABORATORIES INC (IPXL) Stock Chart to make your own analysis
- IMPAX LABORATORIES INC (IPXL) Latest news and press-releases to stay up to date.
Does IMPAX LABORATORIES INC (IPXL) stock pay dividends?
IPXL does not pay a dividend.
What is the Price/Earnings (PE) ratio of IMPAX LABORATORIES INC (IPXL)?
The PE ratio for IMPAX LABORATORIES INC (IPXL) is 29.05. This is based on the reported non-GAAP earnings per share of 0.63 and the current share price of 18.3 null. Check the full fundamental report for a full analysis of the valuation metrics for IPXL.
IPXL Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to IPXL. When comparing the yearly performance of all stocks, IPXL is one of the better performing stocks in the market, outperforming 79.03% of all stocks.
IPXL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to IPXL. While IPXL is still in line with the averages on profitability rating, there are concerns on its financial health.
IPXL Financial Highlights
Over the last trailing twelve months IPXL reported a non-GAAP Earnings per Share(EPS) of 0.63. The EPS decreased by -45.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -60.49% | ||
| ROA | -34.73% | ||
| ROE | -250.69% | ||
| Debt/Equity | 4.11 |